Form 8-K - Current report:
SEC Accession No. 0000950170-25-002076
Filing Date
2025-01-06
Accepted
2025-01-06 16:10:07
Documents
12
Period of Report
2025-01-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20250103.htm   iXBRL 8-K 39664
2 EX-3.1 crdf-ex3_1.htm EX-3.1 166743
  Complete submission text file 0000950170-25-002076.txt   345725

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crdf-20250103.xsd EX-101.SCH 24865
14 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20250103_htm.xml XML 4681
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 25511160
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)